Targeted Therapies for Patients with Unmet Needs

Actinium is developing a pipeline Antibody Radiation Conjugates for targeted conditioning and combination therapies

Actinium to Announce Interim Results from Pivotal Phase 3 SIERRA Trial on Conference Call Scheduled for Monday, October 28th

Conference call and webcast scheduled to start at 12:00 PM ET on Monday, October 28, 2019

Email Sign Up

Receive the latest news, events and updates!

Sign Up Now